RUNX1 and myelodysplastic syndrome: One of the goals of the recently developed ICC and proposed 5th edition of the WHO classification of acute leukemias was to move to a genetically defined classification, and thus, both classifications now recognize MDS‐associated mutations as defining myelodysplasia‐related AML, with only difference being inclusion of RUNX1 in ICC.